Olmefit AM 20 mg/5 mg Tablet
By Olmefit AM
Rx
10 Tablet in a Strip

Composition
Olmesartan Medoxomil(20mg) + Amlodipine(5mg)

Manufacturer - Fidelity Lifesciences Pvt Ltd
3rd Floor, Suvidha House, Plot No. 2, Shipra Society, Vithal Mandir Road, Above Andhra Bank, Karvenagar, Pune 411052

Expires on or after
June, 2026

liver
Olmefit AM 20 mg/5 mg Tablet needs to be approached with caution in individuals with liver conditions. It's important to note that patients with liver disease may require a dosage adjustment when taking Olmefit AM 20 mg/5 mg Tablet. It is advised to consult your doctor before using this medication. In cases where a patient has liver issues, the initiation of Olmefit AM 20 mg/5 mg Tablet should begin at a lower dose and then be gradually increased while closely monitoring the patient's condition to ensure safety and efficacy.

kidney
Olmefit AM 20 mg/5 mg Tablet needs caution in severe kidney disease. Dose adjustment may be necessary. Consult your doctor. Monitor blood pressure regularly.

alcohol
It is not safe to drink alcohol while taking Olmefit AM 20 mg/5 mg Tablet.

driving
Olmefit AM 20 mg/5 mg Tablet may cause side effects like dizziness, headaches, nausea, or tiredness, which may impair your ability to drive. Be cautious as these effects can affect concentration and driving ability.

pregnancy
Olmefit AM 20 mg/5 mg Tablet is not safe to use during pregnancy due to the risk to the developing baby. Only in life-threatening situations, a doctor might prescribe it if benefits outweigh risks. Consult your doctor before using.

breastfeeding
Olmefit AM 20 mg/5 mg Tablet may not be safe during breastfeeding. Limited data shows it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹70
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024